ClinicalTrialsFinder
RecruitingNot ApplicableNCT06520774

Concave Supra-arch Branched Stent-Graft System for Endovascular Treatment of Aortic Arch Diseases

A Prospective, Multicenter, Single-Group Target-Value Clinical Trial: Concave Supra-arch Branched Stent-Graft System for Endovascular Treatment of Aortic Arch Diseases

Sponsor

Lifetech Scientific (Shenzhen) Co., Ltd.

Enrollment

103 participants

Start Date

May 30, 2024

Study Type

INTERVENTIONAL

Conditions

Aortic Arch AneurysmPenetrating Aortic Ulcer

Summary

The objective of the study is to evaluate the safety and efficacy of the Lifetech Concave Supra-arch Branched Stent-Graft System for Endovascular Treatment of Aortic Arch Diseases

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Concave Supra-arch Branched Stent-Graft System for people with aortic arch aneurysm and penetrating aortic ulcer. The study is currently recruiting participants at 17 locations. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEConcave Supra-arch Branched Stent-Graft System

To evaluate the efficacy and safety of Concave Supra-arch Branched Stent-Graft System for endovascular treatment of Aortic Arch Diseases

Locations(17)

Fuwai Hospital, Chinese Academy of Medical Sciences

Beijing, China

Second Xiangya Hospital of Central South University

Changsha, China

West China Hospital, Sichuan University

Chengdu, China

The First Affiliated Hospital of Fujian Medical University

Fuzhou, China

Union Hospital Affiliated to Fujian Medical University

Fuzhou, China

The First Affiliated Hospital of Zhejiang University School of Medicine

Hanzhou, China

The First Affiliated Hospital of Kunming Medical University

Kunming, China

The First People's Hospital of Yunnan Province

Kunming, China

Yunnan Fuwai Cardiovascular Disease Hospital

Kunming, China

Jiangsu Provincial People's Hospital

Nanjing, China

Nanjing First Hospital

Nanjing, China

Zhongshan Hospital of Fudan University

Shanghai, China

Shenzhen Hospital of Fuwai Hospital of Chinese Academy of Medical Sciences

Shenzhen, China

Renmin Hospital of Wuhan University

Wuhan, China

Cardiovascular Disease Hospital Affiliated to Xiamen University

Xiamen, China

The First Affiliated Hospital of Zhengzhou University

Zhengzhou, China

Universitäts-Herzzentrum Freiburg - Bad Krozingen

Freiburg im Breisgau, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06520774

Related Trials

GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study

NCT0716613312 locations

Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA

NCT0708957621 locations

Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms

NCT015242111 location

European Aortic Data Collection Project

NCT0589639718 locations

Guo's Aortic Arch Reconstruction: A Multicenter, Prospective Study of the Novel WeFlow-Tribranch System (GENIUS Study)

NCT0638537920 locations